Literature DB >> 18280358

Potency of the botulinum toxin product CNBTX-A significantly exceeds labeled units in standard potency test.

Terrence Hunt, Kenneth Clarke.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18280358     DOI： 10.1016/j.jaad.2007.11.015

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  4 in total

Review 1.  Temporal characteristics of botulinum neurotoxin therapy.

Authors:  Frank J Lebeda; Regina Z Cer; Robert M Stephens; Uma Mudunuri
Journal:  Expert Rev Neurother       Date:  2010-01       Impact factor: 4.618

Review 2.  Comparison and overview of currently available neurotoxins.

Authors:  Thomas J Walker; Steven H Dayan
Journal:  J Clin Aesthet Dermatol       Date:  2014-02

3.  Characterization of SNARE cleavage products generated by formulated botulinum neurotoxin type-a drug products.

Authors:  Terrence Hunt; David Rupp; Gary Shimizu; Karen Tam; Julia Weidler; Jack Xie
Journal:  Toxins (Basel)       Date:  2010-08-19       Impact factor: 4.546

Review 4.  Botulinum toxin type A products are not interchangeable: a review of the evidence.

Authors:  Mitchell F Brin; Charmaine James; John Maltman
Journal:  Biologics       Date:  2014-10-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.